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Objectives. To evaluate the feasibility and the mid-term results of subintimal angioplasty (SA) in the treatment of critical
limb ischaemia (CLI) with tibial vessels occlusions.
Materials and methods. Between August 2000 and March 2005, we attempted to treat 46 patients (23 men, 23 women,
median age of 75 years; range 35e92) and 50 limbs by SA of occluded tibial vessels. Twenty-one had gangrene, 25 ulcer-
ations and 4 had rest pain. Thirty-nine occlusions (78%) were more than 10 cm in length, 28 (56%) involved popliteal and
tibial artery and distal re-entry was at the ankle level in 18 cases (36%). Twenty-eight patients (61%) were diabetics.
Results. There were nine technical failures. Five of these patients were successfully treated medically (1), by conventional
surgery (1) or by conventional angioplasty of another diseased tibial vessel (3). The four remaining patients had major
amputation and 3 died within 3 months. There were 7 complications including 2 embolisms, 1 perforation and 4 haema-
tomas. By intention to treat, one-year primary, secondary and clinical patency rates were 46%, 55% and 63%, respectively.
One and two-year limb salvage rates were 87%. One and two-year survival rates were 74% and 64%, respectively.
Conclusions. SA of tibial vessel occlusions is a valuable treatment of CLI. Technical failures do not preclude conventional
surgery when there is a valuable outflow. Complications may often be treated medically or by endovascular procedures.
Results have to be confirmed by long-term follow up. Both techniques should be considered as complementary techniques
in the management of CLI.
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Critical limb ischaemia (CLI) with tibial vessels occlu-
sions is a challenge for vascular surgeons. Surgery
with great saphenous vein is still the gold standard
with good results in terms of patency and limb sal-
vage rates.1e8 But CLI often affects elderly patients
with severe co-morbidities who are poor candidates
for this kind of surgery. Subintimal angioplasty
described by A Bolia in 1987,9 relies on the creation
of a dissection in the arterial wall with a hydrophilic
wire to create a ‘‘disease-free channel’’ to the distal
patent artery. The aim of this report is to evaluate
the feasibility and the mid-term results of subintimal
angioplasty of tibial vessels occlusions in critical
limb ischemia.
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From August 2000 until March 2005 we attempted to
treat 46 patients and 50 limbs with CLI and tibial ves-
sel occlusions (Table 1). There were 23 men and 23
women aged 35e92 years (median 75 years).
Twenty-one had gangrene (toe or extended necrosis
treated by limited amputation to achieve healing), 25
had ulcerations and 4 had rest pain. Twenty-eight
patients (61%) were diabetics, 33 (72%) had hyperten-
sion, 36 (78%) coronary artery disease, 7 (15%) had
severe renal insufficiency with 3 on chronic haemo-
dialysis. Four patients had a failed bypass in the
affected leg. Thirty-nine occlusions (78%) were more
than 10 cm in length, 28 (56%) involved popliteal
and a tibial artery and distal re-entry was at the ankle
level in 18 cases (36%) (Table 2). All procedures were
performed by the author in the operating room under
regional anaesthesia. Antegrade common femoral
artery puncture was performed with a 5 or 6 French
sheath. The subintimal dissection was performed
with an angled 0.03500 hydrophilic guide wire (Ter-
umo) and a 5F femorovertebral catheter (Terumo).rved.
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4000 units of heparin were administrated and the
guide wire was exchanged with stiffer wire with
hydrophilic extremity (V 18 Boston Scientific). Angio-
plasty was then performed with a symmetry balloon
(Boston Scientific) of 3 mm wide and 40 mm length
with short (10 to 20 sec) and high pressure inflations
(10 to 15 atm) from the distality to the proximal entry.
No stents were used. Technical success was defined as
good antegrade flow at the completion of the proce-
dure and patency was confirmed by continuous
doppler after the first 24 hours. During hospitalisa-
tion, patients were given low molecular weight Hep-
arin, local application of 10 mg of Nitroglycerine
once-daily (transdermal patch on the calf) and
160 mg Aspirin PO daily indefinitely. Follow-up was
done at 1, 3, 6, 9, 12 and 18 months with clinical exam-
ination and duplex ultrasound.
Primary, secondary and clinical patency rates are
reported by intention to treat, i.e. technical failures
are considered as failures. Patency rates were ana-
lysed with the Kaplan-Meier method.
Results
There were 9 technical failures (18%). Five of these
patients were successfully treated medically (1), by
Table 2. Occlusion characteristics
Length
>10 cm 39 (78%)
<10 cm 11
Extension
Poplitealþ tibial 28 (56%)
Tibial alone 22
Distal re-entry
Calf level 32
Ankle level 18 (36%)
Table 1. Patient characteristics
Patients/limbs 46/50
Median age (range) 75 years (35e92)
Male/female 23/23
Co-morbidities (46 patients)
Diabetes 28 (61%)
Hypertension 33 (72%)
Coronary artery disease 36 (78%)
Renal insufficiency 7 (15%)
Chronic haemodialysis 3 (6%)
Lesions (50 limbs)
Gangrene 21 (42%)
Ulceration 25 (50%)
Rest pain 4 (8%)
Previous occluded bypass 4 (8%)Eur J Vasc Endovasc Surg Vol 32, December 2006femorotibial bypass (1) or by conventional angio-
plasty of another diseased tibial vessel (3). The re-
maining four patients had major amputation despite
surgical exploration or bypass (no run-off or very
diseased distal vessels with early occlusion of the
bypass). Three of these patients died within 3 months
of the amputation. There was no operative mortality.
There were 7 local complications including 2 embo-
lisms (treated by thromboaspiration), 1 perforation
(treated by surgical drainage) and 4 groins haemato-
mas (2 treated by compressions and 2 by surgery).
There were 9 clinical failures (18%). Three late re-
occlusions were successfully treated by conventional
surgery at 5, 8 and 9 months. Two were treated by
redo of SA at 2 and 3 months but re-occluded and
were treated medically for 1 and by above the knee-
amputation for the other. Four patients declined fur-
ther treatment. Two of these patients died within 3
months after re-occlusion, the 2 remaining consulted
another physician.
When last assessed at a median follow up of 15
months (range:2e53) 32 patients had clinical success
(64%). 22 patients had a patent angioplasty site and
no symptoms, 5 had asymptomatic late occlusion
and 5 had symptomatic restenosis successfully treated
by conventional angioplasty or SA.
Primary, secondary and clinical patency rates were
46%, 55% and 63% at one-year and 42%, 52% and 63%
at two-years respectively. (Table 3)
There were 5 major amputations including 4 in the
technical failures group and 1 after late re-occlusion of
the SA at 9 months. One and two-year limb salvage
rates were 87%.
Sixteen of the 46 patients (35%) died in the follow-
up period. Causes of death included cardiovascular
disease in 10 and pulmonary disease in 6. One and
two-year survival rates were 74% and 64% respec-
tively. We also analysed the influence of diabetes, gen-
der and type of clinical lesion (gangrene versus
ulceration or rest pain) on technical success, second-
ary and clinical patency rates (Table 4). Female
patients had improved results in term of secondary
and clinical patency. The presence of diabetes and
the location of the distal re-entry has no influence
Table 3. Patency rates at 1, 12 and 24 months (standard error <10%
at 24 months)
1 month 12 months 24 months
Primary patencya 74% 46% 42%
Secondary patencya 76% 55% 52%
Clinical patencya 78% 63% 63%
Limb salvage 92% 87% 87%
Survival 100% 74% 64%
a In intention to treat.
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N of limb Technical failures n (%) Statisticala Secondary patency
rate (1 year)
Statisticalb Clinical patency
rate (1 year)
Statisticalb
Diabetic 31 5 (16%) NS 56% NS 58% NS
Non-diabetic 19 4 (21%) 41% 66%
Male 24 7 (29%) NS 39% P¼ 0.061 40% P¼ 0.017
Female 26 2 (8%) 69% 80%
Rest pain
or ulceration
29 3 (10%) NS 61% NS 71% NS
Gangrene 21 6 (29%) 46% 47%
<10 cm 11 1 (9%) NS 91% P¼ 0.032 91% NS
>10 cm 39 8 (21%) 43% 52%
Tibial re-entry 32 6 (19%) NS 44% NS 53% NS
Distal re-entry 18 3 (17%) 72% 72%
Popliteal into
crural artery
28 6 (21%) NS 36% P¼ 0.058 45% P¼ 0.050
Crural artery 22 3 (14%) 78% 82%
a Fisher exact test.
b Comparison between survival curves (Kaplan Meier).on outcome. The length of the occlusion and the re-
quirement to extend treatment to the popliteal artery
influenced the secondary and clinical patency rates.
Discussion
Without aggressive treatment, CLI often leads to
major amputation with consequence in terms of qual-
ity of life and cost.10e11 Conventional bypass with the
great saphenous vein is still considered as the gold
standard with good results in terms of patency and
limb salvage rates.1e8 However, a high rate of reinter-
ventions is required to achieve good results. In the
Nicoloff report,12 only 14% of the patients had non-
complicated vascular surgery with loss of the symp-
toms, healing of the wounds by first intention and
no secondary intervention with a functional limb.
Conventional angioplasty allows the treatment of
older patients with severe co-morbidities. Technical
success is achieved in 70% to 96%,13e14 secondary
patency at 3 years is approximately 46%14 and limb
salvage rates range from 77% to 90%.14e15
The results of conventional angioplasty are poor for
multilevel stenosis or long occlusions.16e17 We exam-
ined the value of SA for treating tibial occlusions.
Our first report18 confirmed the good results of SA
of tibial vessels occlusions when surgery was not pos-
sible or considered high risk. Now we have changed
our policy and treat CLI with tibial vessel disease by
conventional angioplasty or SA as first choice. Exclu-
sions from endovascular treatment include embolic
or aneurysmal disease or very extensive disease in
a debilitated patient.Our technical failure rate was 18%, similar to other
series,19 and reflects our aggressive policy. Four of the
9 technical failures had secondary amputation despite
surgical exploration. Three of these patients achieved
limb salvage by other approaches.
During follow-up there was a high rate of late
occlusions (19 or 46%). Only 6 of these patients had
recurrence of symptoms. Five patients remained symp-
tomatic on medical treatment and 1 had a major ampu-
tation. The others had asymptomatic occlusion (5) or
could be treated successfully by conventional angio-
plasty, redo SA (5) or by conventional surgery (3). Our
long term patency rates are lower than those obtained
by bypass surgery and confirm that SA of tibial vessels
is only indicated in CLI where temporary improvement
of the vascularisation is enough to achieve the healing
of the ulcer or amputation site. Healing probably
reduces the oxygen demand of the extremity. Moreover
in case of early or late occlusion, SA does not preclude
conventional surgery. The use of Ticlopidine and
Statins may improve the patency rates.20e21
The overall cost of SA is quite low. The materials
used are relatively simple and inexpensive (standard
angiographic materials and a balloon catheter). The
procedure is performed under local or regional anaes-
thesia,22 there is no intensive care requirement in the
majority of cases and the post operative stay is short
unless the patient had complementary treatment
like localised amputation or surgical debridment of
extended ulcerations.
One other advantage of SA over surgery is the pos-
sibility to target the revascularisation to one infected
or ulcerated area where surgery may be contra-
indicated (Figs. 1 and 2).Eur J Vasc Endovasc Surg Vol 32, December 2006
666 H. Vraux and N. BertoncelloFig. 1. Extended necrosis of the foot in a 47 years-old diabetic patient: before surgery and angioplasty and final result.We perform recanalizations using ‘‘road mapping’’
and regional anaesthesia thereby minimising injection
of contrast. The procedures are often performed with
<100 ml of contrast and may be used in patients with
renal impairment. Regional anesthesia also permits
debridment of ulceration or localized amputation dur-
ing the procedure and may reduce arterial spasm.Eur J Vasc Endovasc Surg Vol 32, December 2006Our results suggest that SA of tibial vessel occlu-
sions is a valuable alternative to surgery and the first
line treatment in patients with CLI. We report a high
technical and clinical success, low morbidity and mor-
tality from tibial SA. Technical failure or late occlusion
does not preclude later conventional surgery in the
majority of the cases. The failure of tibial SA to beFig. 2. Same patient: arteriogram at the ankle level: Tight stenosis of pedal artery (1) and occlusion of distal posterior tibial
artery (2): after conventional angioplasty of pedal artery (3) and subintimal angioplasty of posterior tibial artery (4).
667Subintimal Angioplasty of Tibial Vessel Occlusions in Critical Limb Ischaemiaadopted widely may be due to the long learning curve
required to achieve good results.
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